Harnessing Schistosoma-associated metabolite changes in the human host to identify biomarkers of infection and morbidity: Where are we and what should we do next?
Schistosomiasis is the second most widespread parasitic disease affecting humans. A key component of today's infection control measures is the diagnosis and monitoring of infection, informing individual- and community-level treatment. However, newly acquired infections and/or low parasite burde...
Saved in:
Main Authors: | Mireille Kameni (Author), Fungai Musaigwa (Author), Leonel Meyo Kamguia (Author), Severin Donald Kamdem (Author), Gladice Mbanya (Author), Poppy H L Lamberton (Author), Justin Komguep Nono (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?
by: Giacomo Cavallaro, et al.
Published: (2022) -
Where we are, where we are going
by: Teresa Bermejo-Vicedo, et al.
Published: (2020) -
Where are we now and where are we headed?
by: Ewan A. Langan
Published: (2023) -
2023-2024 - Where we are and where we want to be!
by: Tiago Torres, et al.
Published: (2023) -
Pediatric Sepsis Research: Where Are We and Where Are We Going?
by: Letícia Massaud-Ribeiro, et al.
Published: (2022)